Payment overview · 2025
General Payments
$24.90
1 reported records · 1 companies
Healthcare provider profile · identity verified
Michael Whitford, MD
Allopathic & Osteopathic Physicians|Family Medicine · METAMORA, IL · NPI 1164439980
Verified facts
What the public records show
CMS Open Payments records show Michael Whitford, MD received $24.90 in general payments during 2025 across 1 reported records.
Boston Scientific Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $24.90 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $24.90 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| WATCHMAN Access System Normalized: watchman access system |
Device | Boston Scientific Corporation | $24.90 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 798 | 144 |
| Furosemide | Furosemide | 570 | 66 |
| Amlodipine Besylate | Amlodipine Besylate | 536 | 96 |
| Lisinopril | Lisinopril | 522 | 98 |
| Levothyroxine Sodium | Levothyroxine Sodium | 504 | 107 |
| Metoprolol Succinate | Metoprolol Succinate | 386 | 69 |
| Pantoprazole Sodium | Pantoprazole Sodium | 377 | 75 |
| Tamsulosin Hcl | Tamsulosin Hcl | 348 | 75 |
| Gabapentin | Gabapentin | 338 | 59 |
| Metoprolol Tartrate | Metoprolol Tartrate | 299 | 45 |
| Simvastatin | Simvastatin | 290 | 68 |
| Eliquis | Apixaban | 286 | 37 |
| Omeprazole | Omeprazole | 280 | 76 |
| Losartan Potassium | Losartan Potassium | 275 | 79 |
| Metformin Hcl | Metformin Hcl | 272 | 68 |
| Lorazepam | Lorazepam | 247 | 53 |
| Tramadol Hcl | Tramadol Hcl | 229 | 58 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 215 | 62 |
| Sertraline Hcl | Sertraline Hcl | 215 | 30 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 211 | 45 |
| Allopurinol | Allopurinol | 209 | 33 |
| Glimepiride | Glimepiride | 201 | 47 |
| Escitalopram Oxalate | Escitalopram Oxalate | 196 | 37 |
| Potassium Chloride | Potassium Chloride | 172 | 36 |
| Citalopram Hbr | Citalopram Hydrobromide | 165 | 19 |
| Alprazolam | Alprazolam | 150 | 31 |
| Carvedilol | Carvedilol | 143 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 141 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 139 | 34 |
| Prednisone | Prednisone | 135 | 64 |
| Mirtazapine | Mirtazapine | 133 | 26 |
| Montelukast Sodium | Montelukast Sodium | 133 | 40 |
| Atenolol | Atenolol | 128 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 128 | 35 |
| Donepezil Hcl | Donepezil Hcl | 120 | suppressed |
| Memantine Hcl | Memantine Hcl | 110 | suppressed |
| Jardiance | Empagliflozin | 109 | 23 |
| Famotidine | Famotidine | 104 | 21 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 103 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 102 | 20 |
| Trazodone Hcl | Trazodone Hcl | 101 | 25 |
| Hydralazine Hcl | Hydralazine Hcl | 99 | 18 |
| Azithromycin | Azithromycin | 98 | 64 |
| Finasteride | Finasteride | 93 | 16 |
| Ezetimibe | Ezetimibe | 92 | 22 |
| Glipizide | Glipizide | 90 | 19 |
| Bupropion Xl | Bupropion Hcl | 88 | 14 |
| Alendronate Sodium | Alendronate Sodium | 87 | 21 |
| Ozempic | Semaglutide | 87 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 86 | 27 |
| Celecoxib | Celecoxib | 83 | 24 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 81 | 24 |
| Paroxetine Hcl | Paroxetine Hcl | 80 | 20 |
| Warfarin Sodium | Warfarin Sodium | 78 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 77 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 76 | 20 |
| Myrbetriq | Mirabegron | 76 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 70 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 69 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 69 | suppressed |
| Topiramate | Topiramate | 69 | suppressed |
| Baclofen | Baclofen | 68 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 64 | 28 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 59 | 12 |
| Labetalol Hcl | Labetalol Hcl | 58 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 58 | suppressed |
| Cephalexin | Cephalexin | 57 | 45 |
| Amoxicillin | Amoxicillin | 54 | 40 |
| Pioglitazone Hcl | Pioglitazone Hcl | 54 | 14 |
| Benazepril Hcl | Benazepril Hcl | 53 | 15 |
| Xarelto | Rivaroxaban | 53 | suppressed |
| Ibuprofen | Ibuprofen | 52 | suppressed |
| Pregabalin | Pregabalin | 52 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 52 | 13 |
| Gemfibrozil | Gemfibrozil | 51 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 50 | suppressed |
| Levetiracetam | Levetiracetam | 50 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 44 | 25 |
| Divalproex Sodium | Divalproex Sodium | 44 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 43 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 42 | suppressed |
| Rivastigmine | Rivastigmine | 42 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 41 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 39 | suppressed |
| Spironolactone | Spironolactone | 39 | 12 |
| Mounjaro | Tirzepatide | 38 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 30 |
| Methylphenidate Hcl | Methylphenidate Hcl | 37 | suppressed |
| Januvia | Sitagliptin Phosphate | 34 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 33 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 32 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 32 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 31 | suppressed |
| Digoxin | Digoxin | 31 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 31 | 14 |
| Meloxicam | Meloxicam | 31 | 16 |
| Novolog Flexpen | Insulin Aspart | 31 | suppressed |
| Fluconazole | Fluconazole | 30 | 20 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 14 |
| Clonidine Hcl | Clonidine Hcl | 29 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 22 |
| Terazosin Hcl | Terazosin Hcl | 28 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 27 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 27 | suppressed |
| Folic Acid | Folic Acid | 27 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 27 | suppressed |
| Olanzapine | Olanzapine | 27 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | 21 |
| Estradiol | Estradiol | 26 | suppressed |
| Fenofibrate | Fenofibrate | 26 | suppressed |
| Glipizide Er | Glipizide | 26 | suppressed |
| Ramipril | Ramipril | 26 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 25 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 25 | suppressed |
| Risperidone | Risperidone | 25 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 25 | suppressed |
| Colchicine | Colchicine | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | suppressed |
| Nystatin | Nystatin | 23 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 19 |
| Ondansetron Odt | Ondansetron | 22 | suppressed |
| Synthroid | Levothyroxine Sodium | 22 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 21 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Azathioprine | Azathioprine | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | 13 |
| Farxiga | Dapagliflozin Propanediol | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 18 | suppressed |
| Latanoprost | Latanoprost | 17 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 17 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 17 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | 14 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Dutasteride-Tamsulosin | Dutasteride/Tamsulosin Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 12 |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Belsomra | Suvorexant | 13 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Silodosin | Silodosin | 13 | suppressed |
| Testosterone | Testosterone | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Fentanyl | Fentanyl | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Admelog Solostar | Insulin Lispro | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | 11 |
| Cilostazol | Cilostazol | 11 | suppressed |
| Clonazepam | Clonazepam | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Triazolam | Triazolam | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $24.90 · 1 records | Boston Scientific Corporation | WATCHMAN Access System | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error